Why Palliative Care Applies to Parkinson's Disease
2018; Wiley; Volume: 33; Issue: 5 Linguagem: Inglês
10.1002/mds.27309
ISSN1531-8257
AutoresRaquel Bouça‐Machado, Herma Lennaerts‐Kats, Bastiaan R. Bloem, Joaquim J. Ferreira,
Tópico(s)Neurological and metabolic disorders
ResumoMovement DisordersVolume 33, Issue 5 p. 750-753 Viewpoint Why Palliative Care Applies to Parkinson's Disease Raquel Bouça-Machado MSc, Raquel Bouça-Machado MSc Instituto de Medicina Molecular, Lisbon, Portugal CNS-Campus Neurológico Sénior, Torres Vedras, PortugalSearch for more papers by this authorHerma Lennaerts-Kats, Herma Lennaerts-Kats Radboud University Medical Center, Department of Neurology, Department of Anaesthesiology, Pain and Palliative Care, Nijmegen, The NetherlandsSearch for more papers by this authorBastiaan Bloem MD, PhD, Bastiaan Bloem MD, PhD Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The NetherlandsSearch for more papers by this authorJoaquim J. Ferreira MD, PhD, Corresponding Author Joaquim J. Ferreira MD, PhD joaquimjferreira@gmail.com Instituto de Medicina Molecular, Lisbon, Portugal CNS-Campus Neurológico Sénior, Torres Vedras, Portugal Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, PortugalCorrespondence to: Joaquim J. Ferreira, MD, Laboratorio de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal; joaquimjferreira@gmail.comSearch for more papers by this author Raquel Bouça-Machado MSc, Raquel Bouça-Machado MSc Instituto de Medicina Molecular, Lisbon, Portugal CNS-Campus Neurológico Sénior, Torres Vedras, PortugalSearch for more papers by this authorHerma Lennaerts-Kats, Herma Lennaerts-Kats Radboud University Medical Center, Department of Neurology, Department of Anaesthesiology, Pain and Palliative Care, Nijmegen, The NetherlandsSearch for more papers by this authorBastiaan Bloem MD, PhD, Bastiaan Bloem MD, PhD Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Nijmegen, The NetherlandsSearch for more papers by this authorJoaquim J. Ferreira MD, PhD, Corresponding Author Joaquim J. Ferreira MD, PhD joaquimjferreira@gmail.com Instituto de Medicina Molecular, Lisbon, Portugal CNS-Campus Neurológico Sénior, Torres Vedras, Portugal Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, PortugalCorrespondence to: Joaquim J. Ferreira, MD, Laboratorio de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal; joaquimjferreira@gmail.comSearch for more papers by this author First published: 13 February 2018 https://doi.org/10.1002/mds.27309Citations: 10 Relevant conflicts of interest/financial disclosures: : The authors declare that there are no conflicts of interest relevant to this work. Funding agencies: : No specific funding was received for this work. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume33, Issue5May 2018Pages 750-753 RelatedInformation
Referência(s)